Return to List

Study Summary
No. 2005-0656:.......Lymphoma; Myeloma......Sattva S. Neelapu......Lymphoma/Myeloma
.
Study Summary Title
Study Summary
Number:		2005-0656
Study Title:A Collection of Blood and Tissue Samples from Patients with
Lymphoma and/or Myeloma and Normal Donors
.
Physician New Patient Referral
Name:Sattva S. NeelapuPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Lymphoma/MyelomaReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-2860
Contact us about clinical trials
.
General Information
Disease Group:Lymphoma
Myeloma		Supported By:N/A
Phase of Study:N/AReturn
Visit:		The patients will not be required to return to the clinic for any additional
visits than what is deemed necessary by his or her physician in the course of
their treatment.
Treatment
Agents:		NoneHome Care:None
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:		The patients will not be required to undergo any additional hospitalization
than what is deemed necessary by his or her physician in the course of their
treatment.
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
1. To collect blood, marrow, and tissue samples from patients with lymphoma and/or myeloma at various stages of their disease and treatment for laboratory analyses aimed at understanding the biology of the disease and to evaluate novel treatments for lymphoma and myeloma.
2. To correlate parameters measurable from blood and tissue samples with the natural history and outcome of patients with lymphoma and myeloma.
3. To provide tumor cells to investigators to study the pathogenesis, biological characteristics, immunologic responses, and response to therapy.
4. To collect blood and marrow samples from normal donors for comparison with samples from patients with lymphoma and/or myeloma.
.
Study Status Information
Study Activation / Registration Date:02/02/2007
IRB Review and Approval Date:02/15/2006
Study Type:Other
Recruitment Status:Open
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:1) Patients with an established or suspected diagnosis of lymphoma and/or myeloma as well as normal donors. Normal donors will have to be stem cell transplant donors of patients undergoing allogeneic stem cell transplantation at M. D. Anderson Cancer Center.

2) Patients of both genders and all races and nationalities will be solicited.

3) Age >/= 18 years.
Exclusion Criteria:1)
.
Links
Registration Number: Not Applicable Clinical Trial
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center